Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2485 of 6351
-
Spine fracture pain: which procedure works best?
Symptom relief CompletedStudy design: A prospective randomized study is performed and cases are selected where the indication for surgery is a vertebral compression fracture. Object: To assess outcomes and complications in patients undergoing vertebroplasty, kyphoplasty and thermal facet ablation for v…
Sponsor: Szeged University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New scan could spot hidden cancers better
Diagnosis Recruiting nowThis is a multi-arm prospective trial that evaluates the ability of a novel imaging radiolabeled agents to detect metastatic cancer in participants with solid tumors using a gallium 68 (68Ga-) or copper 64 (64Cu-) FAP-2286 tracer. FAP-2286 is a peptidomimetic molecule that that b…
Phase 1 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
Custom brain exercises show promise for schizophrenia thinking skills
Symptom relief CompletedThe primary aim of this study is to provide confirmation that Cognitive Remediation (CR) for schizophrenia, when personalized based on pre-treatment assessment of early auditory processing ability, facilitates improved cognitive and functional outcomes. Additional aims of this st…
Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New uterine sampler aims to make cancer detection less painful
Diagnosis Recruiting nowThis study is related to a previous study from the same group which started in 2014 (NTC02288676, McGill REB A08-M79-13B, MUHC REB 2020-5945) to develop a clinically implementable screening test -DovEEgene: developing and validating a novel molecular test for the early diagnosis …
Sponsor: McGill University • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New antibody drug shows promise for vitiligo in early trial
Disease control CompletedThis study is designed to evaluate the efficacy of AMG 714 for the treatment of adult participants with vitiligo.
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New antibody combo tackles Hard-to-Treat cancers in early trial
Disease control CompletedLVGN7409 is a humanized monoclonal antibody that specifically binds to CD40, and acts as an agonist against CD40. This first in human study of LVGN7409 is designed to establish the maximum tolerated dose (MTD) and/or the recommended dose for expansion (RDE) as well as the recomm…
Phase 1 • Sponsor: Lyvgen Biopharma Holdings Limited • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New study tests smarter smoking cessation strategies
Disease control CompletedThis project will use the Multiphase Optimization Strategy (MOST) to guide the development of optimized treatment strategies for the two most effective smoking cessation medications (Combination Nicotine Replacement \[C-NRT\] and varenicline). The investigators will recruit daily…
Phase 4 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Oxygen clues could unlock better cervical cancer treatment
Knowledge-focused OngoingPatients with locally advanced cervical cancer (LACC) are primarily treated with radiotherapy +/- chemotherapy however 5-year survival rates are \<60% with significant treatment toxicity. Hypoxia is a well-known radioresistant component of solid tumours such as cervical cancer an…
Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New drug combo targets recurrent brain tumors in kids
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of trametinib and everolimus in treating pediatric and young adult patients with gliomas that have come back (recurrent). Trametinib acts by targeting a protein in cells called MEK and disrupting tumor growth. Everolimus i…
Phase 1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Could a new pill fix your body clock? phase 3 trial underway
Symptom relief OngoingThis is a multicenter, double-blind, randomized study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon and matching placebo in male and female participants with DSWPD.
Phase 3 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Can a 12-month egg plan beat a 20-month one for allergy relief?
Disease control OngoingThe investigators want to test the hypothesis that a total period of 12 months of stepwise open egg introduction is not inferior when compared to a total period of 20 months gradual open egg introduction of a certain egg product with regard to full egg tolerance induction.
Sponsor: Dominque Bullens • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Lazy eye study tests best order for glasses and patching
Disease control Recruiting nowA randomized trial to determine whether simultaneous treatment with spectacles and patching has an equivalent VA outcome compared with sequential treatment, first with spectacles alone followed by patching (if needed), for previously untreated amblyopia in children 3 to \<13 year…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New pill SAGE-718 tested for Alzheimer's memory loss
Disease control CompletedThe primary purpose of this study is to evaluate the safety and tolerability of SAGE-718 and its effects on cognitive and neuropsychiatric symptoms in participants with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease (AD).
Phase 2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:18 UTC
-
Could a bladder pill help prevent diabetes?
Disease control Recruiting nowMirabegron (Myrbetriq®, Astellas) is a highly specific and well-tolerated ß3 agonist marketed for overactive bladder. This trial will assess the effects of mirabegron on glucose tolerance and adipose tissue in prediabetic patients
Phase 2 • Sponsor: Philip Kern • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could a simple formula change help babies born dependent on opioids gain weight better?
Disease control CompletedA randomized clinical study in NAS infants managed via the Eat, Sleep, Console (ESC) approach comparing early weight loss on a standard-caloric density versus high-caloric density feeding regimen.
Sponsor: Yale University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New scan may sharpen radiation for Fast-Growing brain cancers
Knowledge-focused CompletedGlioblastoma multiforme (GBM) is the most common primary brain cancer. The treatment of GBM consists of a combination of surgery and subsequent oncological therapy, i.e. radiotherapy, chemotherapy, or combination of both at te same time. If post-operative oncological therapy invo…
Phase 2 • Sponsor: Masaryk Memorial Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Money for milk: study tests if cash help closes breastfeeding gap for tiniest babies
Knowledge-focused CompletedIn the US, the burden of very low birth weight (VLBW; \<1500 g) birth is borne disproportionately by black (non-Hispanic black/African American) mothers who are 2.2-2.6 times more likely than nonblack mothers to deliver VLBW infants. This disparity is amplified because black VLBW…
Sponsor: Rush University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Can a massive kidney database unlock IgA Nephropathy's secrets?
Knowledge-focused Recruiting now1. Establish an IgAN cohort collaboration group and expert committee to carry out registration research. 2. Construct IgAN structured data set standards, formulate structured data collection templates of diagnosis and treatment , and establish multi-center data integration system…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Could two HPV shots be enough? new study tests simpler vaccine schedule
Vaccine OngoingThe goal of this study is to explore and evaluate whether a 2-dose schedule of Gardasil 9 among young and mid-adult women 16-45 years of age is generally safe and immunogenic, with an antibody response that is not inferior to that observed of a 3-dose schedule of Gardasil 9 among…
Phase 4 • Sponsor: Boston Medical Center • Aim: Vaccine
Last updated Jun 27, 2026 12:24 UTC
-
New drug cocktail aims to outsmart advanced cancers
Disease control Recruiting nowThis phase Ib trial is to find out the best dose, possible benefits and/or side effects of talazoparib when given in combination with palbociclib, axitinib, or crizotinib in treating patients with solid tumors that has spread to nearby tissue or lymph nodes (locally advanced) or …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC